BARC Barclays PLC

Barclays Announces a Reverse Split of the iPath® Series B S&P 500® VIX Short-Term Futures™ ETNs and the iPath® Series B S&P 500® VIX Mid-Term Futures™ ETNs

Barclays Bank PLC (“Barclays”) announced today that it will implement a 1 for 4 reverse split of two series of iPath® ETNs (together, the “ETNs”): the iPath® Series B S&P 500® VIX Short-Term Futures ETNs (CUSIP: 06748F324) (the “VXX ETNs”) and the iPath® Series B S&P 500® VIX Mid-Term Futures ETNs (CUSIP: 06746P613) (the “VXZ ETNs”). Barclays intends the reverse split for each series of ETNs to be effective at the open of trading on Wednesday, July 24, 2024. Each series of ETNs currently trades on the CBOE BZX Exchange (“CBOE”) under the ticker symbol “VXX” for the VXX ETNs and “VXZ” for the VXZ ETNs.

Barclays has the right (but no obligation) to initiate such a reverse split of the ETNs at its discretion on any business day, as described in the pricing supplement relating to the ETNs. On July 9, 2024, the closing indicative value of the VXX ETNs was $10.2926, and the closing indicative value of the VXZ ETNs was $12.1973.

The record date for the reverse split of each series of ETNs will be effective after the close of business, New York time, on July 23, 2024. The closing indicative value of each series of ETNs on the record date will be multiplied by four to determine the respective reverse-split adjusted value of the relevant series of ETNs. The reverse split for each series of ETNs will be effective at the open of trading on July 24, 2024, and each series of ETNs will begin trading on the CBOE on a reverse-split adjusted basis on such date. The reverse-split adjusted ETNs will have a new CUSIP, but will retain the same ticker symbols.

Investors who, as of the record date, hold a number of ETNs that is not divisible by four will receive one reverse-split adjusted ETN of the relevant series for every four ETNs of the relevant series held on the record date and a cash payment for any odd number of ETNs remaining (the “partials”). The cash amount due on any partials will be determined on July 30, 2024, based on the closing indicative value of the relevant series of reverse-split adjusted ETNs on such date and will be paid by Barclays on August 2, 2024.

For more information regarding the reverse split process, including how the reverse-split adjusted value is determined, see the pricing supplement relating to the ETNs under the heading “Specific Terms of the ETNs— Split or Reverse Split.” The pricing supplement and prospectus relating to each series of ETNs can be found on EDGAR, the SEC’s website at , as well as on the product website at the product page for each of the ETNs listed in the table above at .

An investment in the ETNs involves significant risks and may not be suitable for all investors. The ETNs are riskier than ordinary unsecured debt securities and do not benefit from any principal protection. For more information on risks associated with the ETNs, please see “Selected Risk Considerations” below and the risk factors included in the relevant pricing supplement.

Barclays is the issuer of the ETNs and Barclays Capital Inc. is the issuer’s agent in the distribution. Please contact Barclays for further questions:

  • Financial advisors: Directly contact Barclays at or 1-212-528-7990 to obtain further information.
  • Individual investors: Instruct your broker/advisor/custodian to email us at or to call us at: 1-212-528-7990. You may call in together with your broker/advisor/custodian or have them speak to us on your behalf.

About Barclays

Barclays is a British universal bank. We are diversified by business, by different types of customers and clients, and by geography. Our businesses include consumer banking and payments operations around the world, as well as a full-service corporate and investment bank. For further information about Barclays, please visit our website .

Selected Risk Considerations

An investment in the ETNs described herein involves risks. Selected risks are summarized here, but we urge you to read the more detailed explanation of risks described under “Risk Factors” in the applicable prospectus supplement and pricing supplement.

You May Lose Some or All of Your Principal: The ETNs are exposed to any decrease in the level of the underlying index between the inception date and the applicable valuation date. Additionally, if the level of the underlying index is insufficient to offset the negative effect of the investor fee and other applicable costs, you will lose some or all of your investment at maturity or upon redemption, even if the value of such index has increased. Because the ETNs are subject to an investor fee and any other applicable costs, the return on the ETNs will always be lower than the total return on a direct investment in the index components. The ETNs are riskier than ordinary unsecured debt securities and have no principal protection.

Credit of Barclays Bank PLC: The ETNs are unsecured debt obligations of Barclays Bank PLC and are not, either directly or indirectly, an obligation of or guaranteed by any third party. Any payment to be made on the ETNs, including any payment at maturity or upon redemption, depends on the ability of Barclays Bank PLC to satisfy its obligations as they come due. As a result, the actual and perceived creditworthiness of Barclays Bank PLC will affect the market value, if any, of the ETNs prior to maturity or redemption. In addition, if Barclays Bank PLC were to default on its obligations, you may not receive any amounts owed to you under the terms of the ETNs.

The Performance of the Underlying Indices are Unpredictable: An investment in the ETNs is subject to risks associated with fluctuations, particularly a decline, in the performance of the underlying index. Because the performance of such index is linked to futures contracts on the CBOE® Volatility Index (the “VIX Index”), the performance of the underlying index will depend on many factors including, the level of the S&P 500®, the prices of options on the S&P 500®, and the level of the VIX Index which may change unpredictably, affecting the value of futures contracts on the VIX Index and, consequently, the level of the underlying index. Additional factors that may contribute to fluctuations in the level of such index include prevailing market prices and forward volatility levels of the U.S. stock markets and the equity securities included in the S&P 500®, the prevailing market prices of options on the VIX Index, relevant futures contracts on the VIX Index, or any other financial instruments related to the S&P 500® and the VIX Index, interest rates, supply and demand in the listed and over-the-counter equity derivative markets as well as hedging activities in the equity-linked structured product markets.

Your ETNs Are Not Linked to the VIX Index: The value of your ETNs will be linked to the value of the underlying index, and your ability to benefit from any rise or fall in the level of the VIX Index is limited. The index underlying your ETNs is based upon holding a rolling long position in futures on the VIX Index. These futures will not necessarily track the performance of the VIX Index. Your ETNs may not benefit from increases in the level of the VIX Index because such increases will not necessarily cause the level of VIX Index futures to rise. Accordingly, a hypothetical investment that was linked directly to the VIX Index could generate a higher return than your ETNs.

Market and Volatility Risk: The market value of the ETNs may be influenced by many unpredictable factors and may fluctuate between the date you purchase them and the maturity date or redemption date. You may also sustain a significant loss if you sell your ETNs in the secondary market. Factors that may influence the market value of the ETNs include prevailing market prices of the U.S. stock markets, the index components included in the underlying index, and prevailing market prices of options on such index or any other financial instruments related to such index; and supply and demand for the ETNs, including economic, financial, political, regulatory, geographical or judicial events that affect the level of such index or other financial instruments related to such index.

A Trading Market for the ETNs May Not Develop: Although the ETNs are listed on CBOE, a trading market for the ETNs may not develop and the liquidity of the ETNs may be limited, as we are not required to maintain any listing of the ETNs.

No Interest Payments from the ETNs: You may not receive any interest payments on the ETNs.

Restrictions on the Minimum Number of ETNs and Date Restrictions for Redemptions: You must redeem at least 25,000 ETNs of the same series at one time in order to exercise your right to redeem your ETNs on any redemption date. You may only redeem your ETNs on a redemption date if we receive a notice of redemption from you by certain dates and times as set forth in the pricing supplement.

Uncertain Tax Treatment: Significant aspects of the tax treatment of the ETNs are uncertain. You should consult your own tax advisor about your own tax situation.

The ETNs may be sold throughout the day on the exchange through any brokerage account. There are restrictions on the minimum number of ETNs you may redeem directly with the issuer as specified in the applicable prospectus. Commissions may apply and there are tax consequences in the event of sale, redemption or maturity of ETNs. Sales in the secondary market may result in significant losses.

The S&P 500 VIX Futures Indices are products of S&P Dow Jones Indices LLC ("SPDJI"). S&P®, S&P 500®, and "S&P 500 VIX Short-Term Futures", and "S&P 500® Dynamic VIX Futures" are trademarks of Standard & Poor’s Financial Services LLC ("SPFS"). VIX® is a registered trademark of Chicago Board Options Exchange, Incorporated ("CBOE"). These trademarks have been licensed to S&P Dow Jones Indices LLC ("SPDJI") and its affiliates, and sublicensed to Barclays Bank PLC for certain purposes. The ETNs are not sponsored, endorsed, sold or promoted by SPDJI, SPFS, CBOE or any of their respective affiliates (collectively, "S&P Dow Jones Indices"). S&P Dow Jones Indices does not make any representation or warranty, express or implied, to the owners of the ETNs or any member of the public regarding the advisability of investing in securities generally or in the ETNs particularly or the ability of the S&P 500 VIX Futures Indices to track general market performance.

© 2024 Barclays Bank PLC. All rights reserved. iPath, iPath ETNs and the iPath logo are registered trademarks of Barclays Bank PLC. All other trademarks, servicemarks or registered trademarks are the property, and used with the permission, of their respective owners.

NOT FDIC INSURED · NO BANK GUARANTEE · MAY LOSE VALUE

 

EN
10/07/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Barclays PLC

Barclays: 1 director

A director at Barclays sold 301,957 shares at 303p and the significance rating of the trade was 100/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing C...

 PRESS RELEASE

Barclays Appoints Kieran Whitty as a Co-Head of Healthcare for Europe,...

LONDON--(BUSINESS WIRE)-- Barclays today announces the appointment of Kieran Whitty as Co-Head of Healthcare EMEA (Europe, Middle East and Africa), working alongside Sid Chhibbar, Co-Head of Healthcare EMEA. This appointment reflects Barclays’ effort to continue its growth in the UK and Continental Europe, which is a key focus for Barclays investment bank. Kieran joins Barclays from Bank of America where he spent 18 years, most recently as a Managing Director in the EMEA Healthcare team. He has a strong track record advising clients, with extensive experience and connections across the healt...

 PRESS RELEASE

Barclays Bank PLC Announces Proposed Change to Index Underlying the iP...

NEW YORK--(BUSINESS WIRE)-- Barclays Bank PLC (“Barclays”), as index sponsor for the CIBC Atlas Select Index (the “Index”), announced that it is running a consultation process on proposed changes to the Index. The return on the iPath® Select MLP ETNs (the “ETNs”), which are issued by Barclays Bank PLC, is linked to the performance of the Index. Currently, as described in the prospectus relating to the ETNs, the Index rebalances on a quarterly basis over four index business days. The proposed change would increase the number of days over which each quarterly rebalancing occurs to eight busine...

 PRESS RELEASE

Barclays Launches Barclays Live: A Next-Generation Client Research Por...

LONDON & NEW YORK--(BUSINESS WIRE)-- Today, Barclays announces the launch of Barclays Live, a reimagined client research portal designed to deliver a bespoke experience, tailored to the unique needs of every client. With a sleek interface, enhanced navigation, and cutting-edge analytical tools, Barclays Live empowers clients to seamlessly access critical market insights, anticipate industry trends and make data-led decisions. This press release features multimedia. View the full release here: Introducing the new Barclays Live (Graphic: Business Wire) Key Features of New Barclays Live Hubs: ...

Barclays PLC: Sound Q4 profit reflects income growth across all busine...

Barclays reported higher earnings in the fourth quarter of 2024, also excluding the effect of recent acquisitions and disposals, as a result of higher income across all businesses.

ResearchPool Subscriptions

Get the most out of your insights

Get in touch